Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report

BACKGROUND: Despite increasing effort for treating primary central nervous system lymphoma (PCNSL), the prognosis of human immunodeficiency virus (HIV) -related PCNSL was still unsatisfactory. There is currently a lack of clinical evidence for the application of Bruton tyrosine kinase (BTK) inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ying, Wang, Xiaoxue, Lin, Xuyong, Wang, Jun, Yan, Xiaojing, Wen, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466696/
https://www.ncbi.nlm.nih.gov/pubmed/37644480
http://dx.doi.org/10.1186/s12981-023-00554-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466696/
https://www.ncbi.nlm.nih.gov/pubmed/37644480
http://dx.doi.org/10.1186/s12981-023-00554-8

Ejemplares similares